Heterocyclic compounds and their therapeutic use
AssigneeDarwin Discovery, Ltd.
InventorsHazel Joan Dyke, John Gary Montana
Life of this patent
Estimating the term…
Abstract
N-oxides of formula (i) 1 wherein R1 is CH3, CH2F, CHF2 or CF3; R2 is CH3 or CF3; R3 is F, Cl, Br, CN or CH3; and R4 is H, F, Cl, Br, CN or CH3; and pharmaceutically-acceptable salts thereof, are useful as therapeutic agents, e.g., for the treatment of inflammatory diseases.
Claims10
A method for the treatment of a disease state that is capable of being modulated by inhibition of phosphodiesterase IV or Tumour Necrosis Factor, or that is a pathological condition associated with a function of phosphodiesterase IV, eosinophil accumulation or a function of the eosinophil, said method comprising administering to a person or animal an effective amount of the compound of formula (i) 3
- wherein
- R1 is CH3, CH2F, CHF2 or CF3;
- R2 is CH3 or CF3;
- R3 is F, Cl, Br, CN or CH3;
- and
- R4 is H, F, Cl, Br, CN or CH3;
- or a pharmaceutically-acceptable salt thereof.
Dependencies are inferred from the claim text.